Cargando…

Development of targeted biologics for systemic lupus erythematosus

Detalles Bibliográficos
Autor principal: Lipsky, Peter E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479952/
http://dx.doi.org/10.1186/1479-5876-10-S2-A23
_version_ 1782247483912486912
author Lipsky, Peter E
author_facet Lipsky, Peter E
author_sort Lipsky, Peter E
collection PubMed
description
format Online
Article
Text
id pubmed-3479952
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34799522012-10-26 Development of targeted biologics for systemic lupus erythematosus Lipsky, Peter E J Transl Med Meeting Abstract BioMed Central 2012-10-17 /pmc/articles/PMC3479952/ http://dx.doi.org/10.1186/1479-5876-10-S2-A23 Text en Copyright ©2012 Lipsky; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Lipsky, Peter E
Development of targeted biologics for systemic lupus erythematosus
title Development of targeted biologics for systemic lupus erythematosus
title_full Development of targeted biologics for systemic lupus erythematosus
title_fullStr Development of targeted biologics for systemic lupus erythematosus
title_full_unstemmed Development of targeted biologics for systemic lupus erythematosus
title_short Development of targeted biologics for systemic lupus erythematosus
title_sort development of targeted biologics for systemic lupus erythematosus
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479952/
http://dx.doi.org/10.1186/1479-5876-10-S2-A23
work_keys_str_mv AT lipskypetere developmentoftargetedbiologicsforsystemiclupuserythematosus